STRYKER CORP (SYK) is held by 9 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds opening new positions, 2 funds adding, and 7 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($26.7K bought vs $179.1M sold). 0 members of Congress reported 0 purchases vs 3 sales. Latest close $318.15 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 6, 2026 · Congress to Nov 16, 2026.
Fundsmith · Jensen Investment Management · Veritas Asset Management — 9 tracked funds hold SYK. See all holders.
Insiders bought on the open market (5 purchases, $26.7K) vs 7 sales ($179.1M). Latest buy: Nov 22, 2022. Insider trading 0 members of Congress reported buying (0 purchases vs 3 sales). Politician trading
CHURCH & DWIGHT CO INC /DE/ (CHD) · BADGER METER INC (BMI) · Trane Technologies plc (TT) · AUTOMATIC DATA PROCESSING INC (ADP) · WATERS CORP /DE/ (WAT) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Fundsmith | 6.72% | 2,913,833 | TRIMMED (-4.8%) Q3 filed Nov 16 |
| Jensen Investment Management | 4.50% | 589,670 | TRIMMED (-15.3%) Q3 filed Nov 10 |
| Veritas Asset Management | 3.02% | 533,784 | NEW Q3 filed Nov 5 |
| Saturna Capital | 2.16% | 543,257 | ADDED (+47.9%) Q3 filed Nov 16 |
| Flossbach von Storch | 2.10% | 1,475,371 | ADDED (+173.5%) Q3 filed Oct 28 |
| Generation Investment Management | 1.57% | 512,346 | NEW Q3 filed Nov 16 |
| OrbiMed Advisors | 0.93% | 159,100 | TRIMMED (-12.8%) Q3 filed Nov 16 |
| AKO Capital | 0.15% | 20,624 | TRIMMED (-91.7%) Q3 filed Nov 13 |
| Mairs & Power Funds | 0.01% | 4,072 | TRIMMED (-2.0%) Q3 filed Nov 16 |
| Winslow Capital Management | — | — | EXITED |
| RTW Investments | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: +1.3% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 2,264 of 8,857 filers |
| Long-only filers among them | 2,257 |
| Change vs 2026 Q1 | -8 net · 1,661 entered · 1,669 exited |
| Shares reported, all filers | 305,832,972 |
| Reported value, all filers | $92.1B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus (SIC 3841) |
| Revenue · FY2025 | $25.1B |
| Net income · FY2025 | $3.2B |
| Total assets · FY2025 | $47.8B |
| Shares outstanding | 383,573,046 |
| Market cap (at latest close) | $122.0B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jun 30, 2026.
| Shares short · Oct 15, 2026 | 5,700,373 |
| Share of shares outstanding | 1.49% |
| Days to cover | 2.39 |
Shares short at recent settlements — Jul 31, 2026: 8.3M · Aug 14, 2026: 6.9M · Aug 31, 2026: 7.6M · Sep 15, 2026: 7.7M · Sep 30, 2026: 5.7M · Oct 15, 2026: 5.7M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jun 30, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 36 · Sep 30, 2026: 7K · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jun 30, 2026.
1 insider bought on the open market in the last 90 days (5 purchases, $26.7K), against 7 sales by 2 insiders ($179.1M). Latest buy: Nov 22, 2022.
Source: SEC Form 4 filings. Open-market transactions only.
| Latest open-market buy | Transaction price | Price change since disclosure |
|---|---|---|
| BRAINERD MARY K · 18 shares on Nov 22, 2022 · filed Sep 2, 2026 | $225.19 | +3.1% (close Sep 3, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Sep 3, 2026). The transaction price is what the insider paid; the price change is on closing prices (dividends excluded).
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | STRYKER RONDA E | Sell | 33,466 | $323.19 | $10.8M | SEC filing | |
| Nov 6, 2026 | STRYKER RONDA E | Sell | 131,707 | $324.09 | $42.7M | SEC filing | |
| Nov 6, 2026 | STRYKER RONDA E | Sell | 142,794 | $325.11 | $46.4M | SEC filing | |
| Nov 6, 2026 | STRYKER RONDA E | Sell | 149,357 | $325.97 | $48.7M | SEC filing | |
| Nov 6, 2026 | STRYKER RONDA E | Sell | 82,089 | $327.03 | $26.8M | SEC filing | |
| Nov 6, 2026 | STRYKER RONDA E | Sell | 10,587 | $327.69 | $3.5M | SEC filing | |
| Aug 21, 2026 | Crotty Dylan Bram | Group President | Sell | 441 | $328.61 | $144.9K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Debra King | Officer | 826 | $277.8K | Aug 18, 2026 | SEC filing |
| Aug 17, 2026 | STRYKER RONDA E | Director | 350,000 | $117.2M | Aug 18, 2026 | SEC filing |
| May 28, 2026 | Fletcher Robert S | Officer | 4,544 | $1.4M | May 28, 2026 | SEC filing |
| May 27, 2026 | STRYKER RONDA E | Director | 310,000 | $97.0M | May 26, 2026 | SEC filing |
| May 11, 2026 | Mary Fink | Officer | 5,220 | $1.5M | May 11, 2026 | SEC filing |
| May 11, 2026 | 2023 Mary Fink Living Trust | Officer | 3,500 | $991.9K | May 11, 2026 | SEC filing |
| Feb 2, 2026 | James Andrew Pierce | Officer | 475 | $175.2K | Feb 2, 2026 | SEC filing |
| Nov 20, 2025 | Preston Wells | Officer | 165 | $60.4K | Nov 20, 2025 | SEC filing |
| Nov 14, 2025 | William Berry Jr | Officer | 2,026 | $740.5K | Nov 14, 2025 | SEC filing |
| Nov 5, 2025 | STRYKER RONDA E | Director | 520,000 | $184.6M | Nov 5, 2025 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Form | Price change since disclosure |
|---|---|---|
| Apr 14, 2026 | SCHEDULE 13D/A | -7.0% (close Apr 15, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Apr 15, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Vanguard Capital Management | SC 13G | 25,802,180 | 6.7% | Mar 31, 2026 | SEC filing |
| Apr 14, 2026 | STRYKER RONDA E | SC 13D/A | 15,223,331 | 4.0% | Feb 27, 2026 | SEC filing |
| Mar 27, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Feb 11, 2026 | GREENLEAF TRUST | SC 13G/A | 16,801,654 | 4.4% | Dec 31, 2025 | SEC filing |
| Feb 13, 2025 | GREENLEAF TRUST | SC 13G/A | 17,981,458 | 4.7% | Dec 31, 2024 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
0 members of Congress reported buying (0 purchases vs 3 sales).
Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.
Recent activity by member
| Member | Chamber | Party | Buys | Sells | Latest | Amount range |
|---|---|---|---|---|---|---|
| Kean, Thomas H. | House | R | 0 | 3 | Sep 30, 2026 | $1,001 - $15,000 |
Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.
Industry: Surgical & Medical Instruments & Apparatus (SIC 3841). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.
| Member who traded this stock | Sits on |
|---|---|
| Kean, Thomas H. | House Committee on Energy and Commerce |
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 173 Lobbying Disclosure Act filings named this company as client, 2005–2026; most common issues: Health Issues (144), Medicare/Medicaid (93), Trade (domestic/foreign) (45).
Federal contracts: $539.0M in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $90.6M |
| FY2022 | $80.9M |
| FY2023 | $136.2M |
| FY2024 | $72.9M |
| FY2025 | $71.0M |
| FY2026 | $87.4M |
Largest awards collected
| Award ID | Agency | Amount | Start |
|---|---|---|---|
| 36C10G23K0016 | Department of Veterans Affairs | $10.8M | Apr 30, 2021 |
| 36C25625P1352 | Department of Veterans Affairs | $3.6M | Jul 29, 2025 |
| SPE2D123F0124 | Department of Defense | $3.3M | Apr 11, 2023 |
| SPE2DS23P1882 | Department of Defense | $3.3M | Jul 14, 2023 |
| 36C26223F0608 | Department of Veterans Affairs | $3.1M | Aug 9, 2023 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Financial Screens
· Growth — Revenue up every year for 5 straight years
· Graham — Sound finances and a long run of profits
· Dividend Growth — Dividends raised for more than 10 years
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
· Earnings Stability — Small earnings swings and almost no loss years
Key figures
· Growth — Latest revenue: $25.1B · 5-yr revenue CAGR: 11.8% · Straight growth years: 5
· Graham — Current ratio: 1.89 · Straight profitable years: 19 · Debt ratio: 1.13 · Latest net income: $3.2B
· Dividend Growth — Dividend per share: 1.56 · Dividend yield: 0.5% · Straight dividend years: 10 · 10-yr dividend growth: 374.2%
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.38 · Operating cash flow: $5.0B · Net income: $3.2B
· Earnings Stability — Earnings variation (CV): 0.34 · Loss years (of 10): 0 · Latest net income: $3.2B
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 8 | 37.5% | +0.3% | +2.2% | -1.9% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold SYK — ranked by lift, the co-holding pattern described in Methodology: CHURCH & DWIGHT CO INC /DE/ (CHD) · BADGER METER INC (BMI) · Trane Technologies plc (TT) · AUTOMATIC DATA PROCESSING INC (ADP) · WATERS CORP /DE/ (WAT) · IDEXX LABORATORIES INC /DE (IDXX) · ILLINOIS TOOL WORKS INC (ITW) · 3M CO (MMM).
| Filed | Items | Source |
|---|---|---|
| Nov 9, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 29, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 6, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
CHURCH & DWIGHT CO INC /DE/ (CHD) · Track Record: how the signals scored · Practice timing on SYK
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.